Back to results
US 7,115,610 B2Granted
Substituted heterocyclic compounds
AssigneeCV Therapeutics, Inc.
InventorsElfatih Elzein, Prabha Ibrahim, Venkata Palle, Kenneth Rehder, Jeffrey Zablocki
Life of this patent
Estimating the term…
Abstract
Disclosed are novel substituted heterocyclic derivatives having the structure of Formula I: The compounds are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, diabetes, and myocardial infarction.
Claims18
A compound of Formula I:
- wherein:
- R1, R2, R3, R4, R5, R6, R7, and R8 are hydrgen, lower alkyl, or —C(O)R, in which R is —OR11 or —NR11R12, where R11 and R12 are independently hydrogen or lower alkyl;
- or
- R1 and R2, R3 and R4, R5 and R6, R7 and R8, when taken together with the carbon to which they are attached, represent carbonyl;
- or with the provisos that
- i. the maximum number of carbonyl groups is 1, and
- ii. the maximum number of —C(O)NR11R12 groups is 1,
- R9 is a mono or bicyclic and may be optionally substituted with 1 to 5 substituents selected from substituted alkyl, phenyl, and phenyl substituted with 1 to 3 substituents selected from amino, alkoxy, hydroxy, halogen and CF3;
- R10 is benzothiazol-5-yl optionally substituted with alkyl;
- T is —O—, —S—, —NHSO2—, —SO2NH—, or —CO—NH—;
- Q is —N<
- X is a covalent bond or an optionally substituted alkylene of 1–6 carbon atoms;
- Y is optionally substituted aikylene of 1–3 carbon atoms;
- and
- Z is a covalent bond, —O—, —S—, or —N(R15)—, wherein R15 is hydrogen or C1-4 alkyl.
12 more elements
Dependencies are inferred from the claim text.